Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,7427 USD | +1,81 % | +27,13 % | -46,95 % |
Métier
Nombre d'employés: 233
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Microbiome Therapeutics
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1 672,24 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 7 | 100,0 % | 126 | 100,0 % | +1 672,24 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 01/11/14 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 22/10/20 |
Chief Tech/Sci/R&D Officer | - | 01/05/15 | |
Kelly M. Brady
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Marcus Chapman
COO | Chief Operating Officer | 53 | 01/03/15 |
Lisa von Moltke
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/03/20 |
Barbara McGovern
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/15 |
Matthew Henn
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/06/12 |
Carlo Tanzi
IRC | Investor Relations Contact | - | 01/10/15 |
Teresa Young
PRN | Corporate Officer/Principal | 57 | 29/06/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 01/04/15 |
Director/Board Member | 68 | 04/01/23 | |
Richard Kender
BRD | Director/Board Member | 68 | 06/10/14 |
Kurt Graves
BRD | Director/Board Member | 56 | 01/11/15 |
Paul Biondi
BRD | Director/Board Member | 54 | 20/03/20 |
Eric Shaff
CEO | Chief Executive Officer | 48 | 01/11/14 |
Willard Dere
BRD | Director/Board Member | 70 | 11/07/17 |
Stephen Berenson
CHM | Chairman | 63 | 05/08/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 151 009 462 | 142 384 021 ( 94,29 %) | 0 | 94,29 % |
Coordonnées société
Seres Therapeutics, Inc.
200 Sidney Street 4th floor
02139, Cambridge
+617 945 9626
http://www.serestherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-46,95 % | 110 M | |
-2,26 % | 104 Md | |
+1,41 % | 97,42 Md | |
+0,79 % | 22,2 Md | |
-17,84 % | 21,23 Md | |
-11,11 % | 18,33 Md | |
-42,83 % | 16,35 Md | |
-17,63 % | 15,06 Md | |
+4,55 % | 13,98 Md | |
+32,11 % | 11,66 Md |
- Bourse
- Actions
- Action MCRB
- Société Seres Therapeutics, Inc.